ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,149Medicare Part D Prescriptions Filled, Including Refills

Rank: 100 out of 336

$660K Total Retail Price of All Prescriptions

Rank: 103 out of 336

462 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

16% of this provider’s 462 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 10,198 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
LISINOPRIL 729 535 1 6
OMEPRAZOLE 687 567 2 3
AMLODIPINE BESYLATE 642 476 3 1
SIMVASTATIN 492 406 4 5
ATORVASTATIN CALCIUM 361 300 5 14
METOPROLOL SUCCINATE 341 239 6 15
HYDROCODONE-ACETAMINOPHEN 332 240 S3 7 2
POTASSIUM CHLORIDE 297 254 8 9
LEVOTHYROXINE SODIUM 293 247 9 7
HYDROCHLOROTHIAZIDE 285 236 10 12
METFORMIN HCL 284 187 11 8
PRAVASTATIN SODIUM 273 155 12 10
FUROSEMIDE 265 197 13 4
WARFARIN SODIUM 235 191 14 17
CARVEDILOL 223 170 15 13
METOPROLOL TARTRATE 194 121 16 16
CRESTOR 191 144 17 25
ALENDRONATE SODIUM 182 180 18 54
GABAPENTIN 181 136 19 11
DIOVAN 179 163 20 31
GLIMEPIRIDE 155 123 21 29
FENOFIBRATE 154 116 22 72
NEXIUM 138 58 23 24
ZETIA 118 105 24 74
ALLOPURINOL 113 77 25 30
CITALOPRAM HBR 107 74 26 21
SERTRALINE HCL 106 68 27 33
SPIRIVA 105 68 28 88
RANITIDINE HCL 103 83 29 36
SPIRONOLACTONE 102 81 30 42
CLOPIDOGREL 100 79 31 28
LANTUS 99 75 32 56
DONEPEZIL HCL 98 94 33 27
AMITRIPTYLINE HCL 95 94 R 34 57
LISINOPRIL-HYDROCHLOROTHIAZIDE 86 65 35 23
ZOLPIDEM TARTRATE 80 64 36 18
LOVASTATIN 77 76 37 34
LANTUS SOLOSTAR 77 47 37 124
NIASPAN 75 63 39 139
RAMIPRIL 75 67 39 84
LIPITOR 74 54 41 62
KLOR-CON M20 73 64 42 51
PLAVIX 73 63 42 37
TRAMADOL HCL 72 50 44 20
VYTORIN 67 55 45 122
DIGOXIN 67 48 45 50
ISOSORBIDE MONONITRATE ER 65 65 47 44
CYMBALTA 65 42 47 52
VENLAFAXINE HCL ER 64 51 49 100
GLIPIZIDE ER 64 56 49 91
NIFEDIPINE ER 60 49 51 87
TRICOR 59 53 52 108
LOSARTAN POTASSIUM 56 39 53 22
PAROXETINE HCL 56 33 53 64
CLONIDINE HCL 55 49 55 32
DIOVAN HCT 54 24 56 41
FLUOXETINE HCL 53 19 57 81
ROPINIROLE HCL 53 47 57 98
NOVOLOG 52 41 59 135
PEN NEEDLE 52 41 59 162
DILTIAZEM 24HR CD 51 25 61 126
KLOR-CON 10 51 40 61 75
NAMENDA 51 51 61 39
ESCITALOPRAM OXALATE 50 39 64 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 12, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.